Precice is CE-marked and approved in other select markets. It is a less invasive product and has been used in more than 250 trauma and oncology patients.
“Multiple patients of mine have already benefitted from the all-internal, Precice Bone Transport system,” Dr. Thomas Kern, an orthopedic surgeon in Germany, said in the release. “Being able to utilize the reliable Precice magnetic technology and treat more patients without the need for external fixation or amputation, is something I’m proud to be a part of.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
